Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A; Asia-Pacific Lupus Collaboration.
Lancet Rheumatol. 2023 Oct;5(10):e584-e593. doi: 10.1016/S2665-9913(23)00209-6. Epub 2023 Sep 12.
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?
Bédouelle E, Nguyen JM, Varey E, Khammari A, Dreno B.
Dermatology. 2022;238(3):517-526. doi: 10.1159/000518718. Epub 2021 Oct 27.
Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.
Salman L, Covens A.
Curr Oncol. 2024 Jan 4;31(1):296-306. doi: 10.3390/curroncol31010019.
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L.
J Clin Oncol. 2007 Oct 1;25(28):4414-22. doi: 10.1200/JCO.2007.10.6823. Epub 2007 Sep 4.
Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation.
Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, Högstrand K, Karimi M, Walldin G, Jansson M, Vonlanthen S, Ljungman P, Langemeijer S, Yoshizato T, Hellström-Lindberg E, Woll PS, Jacobsen SEW.
Blood. 2024 Mar 14;143(11):953-966. doi: 10.1182/blood.2023022851.
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.
Ye G, Wu G, Zhang C, Wang M, Liu H, Song E, Zhuang Y, Li K, Qi Y, Liao Y.
Front Immunol. 2024 Jun 12;15:1414954. doi: 10.3389/fimmu.2024.1414954. eCollection 2024.
Continued complete remission without systemic therapy for isolated testicular relapse after bone marrow transplantation in a boy with acute lymphoblastic leukemia.
Kodama Y, Okamoto Y, Ijichi O, Shinkoda Y, Nishikawa T, Tanabe T, Yoshioka T, Tashiro Y, Mougi H, Kawano Y.
Pediatr Transplant. 2009 Sep;13(6):769-72. doi: 10.1111/j.1399-3046.2008.01023.x. Epub 2009 Nov 26.
Acute lymphoblastic leukemia: treatment.
Frei E 3rd, Sallan SE.
Cancer. 1978 Aug;42(2 Suppl):828-38. doi: 10.1002/1097-0142(197808)42:2+<828::aid-cncr2820420704>3.0.co;2-w.
Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?
Steenbruggen TG, Bouwer NI, Smorenburg CH, Rier HN, Jager A, Beelen K, Ten Tije AJ, de Jong PC, Drooger JC, Holterhues C, Kitzen JJEM, Levin M-, Sonke GS.
Breast Cancer Res Treat. 2019 Dec;178(3):597-605. doi: 10.1007/s10549-019-05427-1. Epub 2019 Sep 6.
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysis.
Hess LM, Rong N, Monahan PO, Gupta P, Thomaskutty C, Matei D.
Cancer. 2010 Nov 15;116(22):5251-60. doi: 10.1002/cncr.25487.
